Efficacy of keverprazan for duodenal ulcer: A phase II randomized, double‐blind, parallel‐controlled trial

Evidence-based clinical practice guidelines for peptic ulcer disease 2020

(2021) Tomoari Kamada et al.   JOURNAL OF GASTROENTEROLOGY

Randomised clinical trial: tegoprazan, a novel potassium-competitive acid blocker, or lansoprazole in the treatment of gastric ulcer

(2020) Yu Kyung Cho et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis

(2019) Yinglian Xiao et al.   GUT

Vonoprazan prevents ulcer recurrence during long-term NSAID therapy: randomised, lansoprazole-controlled non-inferiority and single-blind extension study

(2017) Yuji Mizokami et al.   GUT

Peptic ulcer disease

(2017) Angel Lanas et al.   LANCET

Randomised clinical trial: efficacy and safety of vonoprazan vs. lansoprazole in patients with gastric or duodenal ulcers - results from two phase 3, non-inferiority randomised controlled trials

(2016) H. Miwa et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy forHelicobacter pylorieradication: a phase III, randomised, double-blind study

(2016) Kazunari Murakami et al.   GUT

Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects

(2015) H. Jenkins et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The First-in-Class Potassium-Competitive Acid Blocker, Vonoprazan Fumarate: Pharmacokinetic and Pharmacodynamic Considerations

(2015) Hirotoshi Echizen   CLINICAL PHARMACOKINETICS

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising TAK-438 (Vonoprazan) Doses in Healthy Male Japanese/non-Japanese Subjects

(2015) Yuuichi Sakurai et al.   Clinical and Translational Gastroenterology

A Randomized, Comparative Trial of a Potassium-Competitive Acid Blocker (AZD0865) and Esomeprazole for the Treatment of Patients With Nonerosive Reflux Disease

(2013) John Dent et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Reinfection rate of Helicobacter pylori after eradication treatment: a long-term prospective study in Japan

(2012) Susumu Take et al.   JOURNAL OF GASTROENTEROLOGY

Proton Pump Inhibitors

(2009) Kwong Ming Fock et al.   CLINICAL PHARMACOKINETICS

Insights into the future of gastric acid suppression

(2009) Kenneth R. DeVault et al.   Nature Reviews Gastroenterology & Hepatology